[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Procept Biorobotics Corp (PRCT)

Procept Biorobotics Corp (PRCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,207,821
  • Shares Outstanding, K 56,919
  • Annual Sales, $ 308,050 K
  • Annual Income, $ -95,570 K
  • EBIT $ -109 M
  • EBITDA $ -103 M
  • 60-Month Beta 0.87
  • Price/Sales 3.86
  • Price/Cash Flow N/A
  • Price/Book 3.42

Options Overview Details

View History
  • Implied Volatility 87.92% (+4.32%)
  • Historical Volatility 73.12%
  • IV Percentile 92%
  • IV Rank 65.80%
  • IV High 108.86% on 11/04/25
  • IV Low 47.62% on 08/28/25
  • Expected Move (DTE 3) 1.16 (5.99%)
  • Put/Call Vol Ratio 1.04
  • Today's Volume 726
  • Volume Avg (30-Day) 498
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 16,061
  • Open Int (30-Day) 16,021
  • Expected Range 18.15 to 20.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.46
  • Number of Estimates 4
  • High Estimate $-0.36
  • Low Estimate $-0.51
  • Prior Year $-0.35
  • Growth Rate Est. (year over year) -31.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.67 +3.43%
on 07/14/26
25.45 -24.13%
on 06/15/26
-6.40 (-24.88%)
since 06/12/26
3-Month
18.67 +3.43%
on 07/14/26
29.74 -35.07%
on 06/09/26
-5.28 (-21.47%)
since 04/14/26
52-Week
18.67 +3.43%
on 07/14/26
62.17 -68.94%
on 07/18/25
-38.86 (-66.80%)
since 07/14/25

Most Recent Stories

More News
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026

SAN JOSE, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation  (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing...

PRCT : 19.31 (-9.00%)
PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval

SAN JOSE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: completion of enrollment in the...

PRCT : 19.31 (-9.00%)
5 Robotics Stocks to Watch as Physical AI Builds Momentum

As AI moves from the digital world into the physical one, robotics stocks are emerging as one of the market's most compelling early-stage opportunities.

SERV : 5.82 (+0.52%)
OUST : 41.97 (+4.85%)
PRCT : 19.31 (-9.00%)
BOT : 36.71 (+13.23%)
VPG : 110.87 (+4.92%)
AUA Guidelines Strengthen Recommendation for Aquablation® Therapy

SAN JOSE, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) today highlighted the latest update to the American Urological Association (AUA) Guidelines for the management...

PRCT : 19.31 (-9.00%)
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June

SAN JOSE, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative...

PRCT : 19.31 (-9.00%)
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results

SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...

PRCT : 19.31 (-9.00%)
PROCEPT's Q1 Report May Expose the Gap Between Upgrade and Reality

Barchart Research What to Expect from PRCT Earnings PRCT Generated April 28, 2026 Current Price $23.03 EPS Estimate $$-0.55 Consensus Rating Moderate Buy Average Move 8.36% PROCEPT's Q1 Report May Expose...

PRCT : 19.31 (-9.00%)
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, continues its investigation on behalf of PROCEPT BioRobotics Corporation (“Procept” or the “Company”)...

PRCT : 19.31 (-9.00%)
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith continues its investigation on behalf of PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ:  PRCT ) investors concerning the...

PRCT : 19.31 (-9.00%)
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz continues its investigation of PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT ) on behalf of investors concerning...

PRCT : 19.31 (-9.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use...

See More

Key Turning Points

3rd Resistance Point 22.19
2nd Resistance Point 21.87
1st Resistance Point 21.55
Last Price 19.31
1st Support Level 20.91
2nd Support Level 20.59
3rd Support Level 20.27

See More

52-Week High 62.17
Fibonacci 61.8% 45.55
Fibonacci 50% 40.42
Fibonacci 38.2% 35.29
Last Price 19.31
52-Week Low 18.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.